Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 5.996
Filtrar
2.
Recurso de Internet en Inglés, Español, Portugués | LIS - Localizador de Información en Salud | ID: lis-48229

RESUMEN

Campanha mundial da OPAS sobre o Dia Mundial Sem Tabaco de 31 de maio de 2021 O tabaco mata mais de 8 milhões de pessoas por ano. Estudos científicos publicados este ano mostram que os fumantes têm maior risco de desenvolver doença grave e morte por COVID-19 do que não-fumantes. A pandemia de COVID-19 levou milhões de usuários de tabaco a quererem largar o cigarro. Veja mais informações acessando o site


Asunto(s)
Prevención del Hábito de Fumar , Cese del Uso de Tabaco , Tabaquismo/complicaciones , Neumonía Viral/complicaciones , Infecciones por Coronavirus/complicaciones , Pandemias
4.
BMC Infect Dis ; 21(1): 524, 2021 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-34088268

RESUMEN

BACKGROUND: With pandemic of coronavirus disease 2019 (COVID-19), human coronaviruses (HCoVs) have recently attached worldwide attention as essential pathogens in respiratory infection. HCoV-229E has been described as a rare cause of lower respiratory infection in immunocompetent adults. CASE PRESENTATION: We reported a 72-year-old man infected by HCoV-229E with rapid progression to acute respiratory distress syndrome, in conjunction with new onset atrial fibrillation, intensive care unit acquired weakness, and recurrent hospital acquired pneumonia. Clinical and radiological data were continuously collected. The absolute number of peripheral T cells and the level of complement components diminished initially and recovered after 2 months. The patient was successfully treated under intensive support care and discharged from the hospital after 3 months and followed. CONCLUSION: HCoV-229E might an essential causative agent of pulmonary inflammation and extensive lung damage. Supportive treatment was essential to HCoVs infection on account of a long duration of immunological recovery in critical HCoV-229E infection.


Asunto(s)
Resfriado Común/diagnóstico , Coronavirus Humano 229E , Infecciones por Coronavirus/diagnóstico , Neumonía Viral/diagnóstico , Anciano , Antibacterianos/uso terapéutico , Líquido del Lavado Bronquioalveolar/virología , Resfriado Común/complicaciones , Resfriado Común/virología , Infecciones por Coronavirus/complicaciones , Diabetes Mellitus , Neumonía Asociada a la Atención Médica/complicaciones , Neumonía Asociada a la Atención Médica/tratamiento farmacológico , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Masculino , Neumonía Viral/tratamiento farmacológico
6.
Arch. argent. pediatr ; 119(3): e252-e255, Junio 2021. ilus
Artículo en Inglés, Español | LILACS, BINACIS | ID: biblio-1248221

RESUMEN

Las infecciones por coronavirus son habituales en los pacientes pediátricos. Por lo general, producen un cuadro clínico leve de infección del tracto respiratorio superior que no suele afectar a los pulmones, salvo en prematuros y niños con enfermedades crónicas de base. Excepcionalmente, afectan a otros órganos (corazón, cerebro, tracto gastrointestinal) e incrementan su gravedad.En relación con la coincidencia temporal con el inicio de la actual pandemia por el nuevo beta coronavirus (SARS-CoV-2), responsable de su enfermedad asociada (COVID-19), se presenta el caso clínico de un paciente de 5 años con fracaso multiorgánico y secuelas neurológicas por afectación bulbar y trombosis vascular ocasionados por un alfa coronavirus (CoV-NL63) debido a su gravedad y excepcionalidad


Coronavirus infections (CoV) are common in pediatric patients. In general, they produce a mild clinical presentation consisting of an upper respiratory tract infection that does not usually infect the lungs, with the exception of preterm infants and children with chronic diseases. These infections exceptionally affect other organs (heart, brain, gastrointestinal tract), thus increasing their severity.In relation to the temporal coincidence with the beginning of the current situation of pandemic by the new beta coronavirus SARS-CoV-2 responsible for its associated disease (COVID-19), this study presents a clinical case of a 5-year-old patient showing multiple-organ failure and neurological sequelae due to bulbar injury and vascular thrombosis caused by an alpha coronavirus (CoV-NL63) due to its severity and exceptionality


Asunto(s)
Humanos , Masculino , Preescolar , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones por Coronavirus/diagnóstico , Coronavirus Humano NL63/aislamiento & purificación , Insuficiencia Multiorgánica/virología , Infecciones del Sistema Respiratorio/complicaciones , Infecciones por Coronavirus/complicaciones , Diagnóstico Diferencial , Insuficiencia Multiorgánica/diagnóstico
9.
Recurso de Internet en Portugués | LIS - Localizador de Información en Salud | ID: lis-48218

RESUMEN

Após meses de combate e ao estudo da Covid-19, os sintomas causados pela infecção do Sars-CoV-2 já são facilmente reconhecidos pelos profissionais da saúde, facilitando tanto o diagnóstico quanto a manutenção das sequelas – visto que, até o momento, não existe tratamento específico para a doença causada pelo coronavírus. Nesta matéria, especialistas da Universidade Federal de Juiz de Fora (UFJF) explicam como acontece o surgimento e quais as possibilidades de reversão de dois sintomas característicos da Covid-19: a perda de paladar e de olfato.


Asunto(s)
Infecciones por Coronavirus/complicaciones , Betacoronavirus , Neumonía Viral , Gusto , Olfato , Otolaringología
10.
Recurso de Internet en Portugués | LIS - Localizador de Información en Salud | ID: lis-48204

RESUMEN

Um grupo de pesquisa do Departamento de Fisioterapia Cardiorrespiratória e Musculoesquelética da Universidade Federal de Juiz de Fora (UFJF), tem realizado estudos sobre as repercussões funcionais e respiratórias da COVID-19, a curto e médio prazo. O objetivo da pesquisa é compreender os efeitos da COVID-19 durante e após a infecção pelo Sars-CoV-2.


Asunto(s)
Infecciones por Coronavirus , Neumonía Viral , Infecciones por Coronavirus/complicaciones , Neumonía Viral/complicaciones
11.
Rev Neurol ; 72(11): 384-396, 2021 06 01.
Artículo en Inglés, Español | MEDLINE | ID: mdl-34042167

RESUMEN

INTRODUCTION: Many patients with mild or severe COVID-19 do not make a full recovery and have a wide range of chronic symptoms for weeks or months after infection, often of a neurological, cognitive or psychiatric nature. The epidemiological evidence, diagnostic criteria and pathogenesis of post-COVID-19 syndrome are reviewed. DEVELOPMENT: Post-COVID-19 syndrome is defined by persistent clinical signs and symptoms that appear while or after suffering COVID-19, persist for more than 12 weeks and cannot be explained by an alternative diagnosis. The symptoms can fluctuate or cause relapses. It is a heterogeneous condition that includes post-viral chronic fatigue syndrome, sequelae in multiple organs and the effects of severe hospitalisation/post-intensive care syndrome. It has been reported in patients with mild or severe COVID-19 and irrespective of the severity of the symptoms in the acute phase. Between 10% and 65% of survivors who had mild/moderate COVID-19 present symptoms of post-COVID-19 syndrome for 12 weeks or more. At six months, subjects report an average of 14 persistent symptoms. The most common symptoms are fatigue, dyspnoea, anxiety, depression, and impaired attention, concentration, memory and sleep. The underlying biological mechanisms are unknown, although an abnormal or excessive autoimmune and inflammatory response may play an important role. CONCLUSIONS: Clinical manifestations are diverse, fluctuating and variable, although fatigue and neurocognitive complaints predominate. There is no defined consensus on post-COVID-19 syndrome and its diagnostic criteria have not been subjected to adequate psychometric evaluation.


Asunto(s)
COVID-19/complicaciones , SARS-CoV-2 , Autoinmunidad , Encéfalo/metabolismo , COVID-19/diagnóstico , COVID-19/epidemiología , COVID-19/fisiopatología , Enfermedades Cardiovasculares/etiología , Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/fisiopatología , Infecciones por Coronavirus/complicaciones , Disnea/etiología , Síndrome de Fatiga Crónica/etiología , Enfermedades Gastrointestinales/etiología , Hospitalización , Interacciones Huésped-Patógeno , Humanos , Inflamación , Trastornos Mentales/etiología , Enfermedades del Sistema Nervioso/etiología , Especificidad de Órganos , Pandemias , Disautonomías Primarias/etiología , Factores de Riesgo , Síndrome Respiratorio Agudo Grave/complicaciones
12.
Int Arch Allergy Immunol ; 182(9): 863-876, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33951640

RESUMEN

Coronaviruses (CoVs) were first discovered in the 1960s. Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) has been identified as the cause of COVID-19, which spread throughout China and subsequently, across the world. As COVID-19 causes serious public health concerns across the world, investigating the characteristics of SARS-CoV-2 and its interaction with the host immune responses may provide a clearer picture of how the pathogen causes disease in some individuals. Interestingly, SARS-CoV-2 has 80% sequence homology with SARS-CoV-1 and 96-98% homology with CoVs isolated from bats. Therefore, the experience acquired in SARS and Middle East Respiratory Syndrome (MERS) epidemics may improve our understanding of the immune response and immunopathological changes in COVID-19 patients. In the present paper, we have reviewed the immune responses (including the innate and adaptive immunities) to SARS-CoV, MERS-CoV, and SARS-CoV-2, so as to improve our understanding of the concept of the COVID-19 disease, which will be helpful in developing vaccines and medications for treating the COVID-19 patients.


Asunto(s)
Infecciones por Coronavirus/inmunología , Coronavirus/inmunología , Interacciones Huésped-Patógeno/inmunología , Inmunidad , Inmunidad Adaptativa , Enzima Convertidora de Angiotensina 2/metabolismo , Animales , Biomarcadores , COVID-19/complicaciones , COVID-19/inmunología , COVID-19/prevención & control , COVID-19/virología , Coronavirus/fisiología , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/virología , Citocinas/metabolismo , Humanos , Inmunidad Innata , SARS-CoV-2/inmunología , SARS-CoV-2/fisiología , Vacunas Virales/inmunología
13.
Clin Nutr ESPEN ; 43: 9-15, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-34024569

RESUMEN

Respiratory Viruses infections (RVI) such as rhinovirus, coronavirus, influenza virus, and adenovirus affect the respiratory and the immune systems. The role of nutrition in the respiratory and immune systems has been studied in some studies, and its importance is undeniable. In addition, one of the key findings in this disease is high inflammation that affects almost all patients. This systematic narrative review aims to answer the question, "Can an anti-inflammatory diet be effective in preventing or treating viral respiratory diseases?" A systematic review search was used for the articles extraction. All studies published in English from 1999 to 2020 investigating dietary inflammatory conditions and RVI were included. Food items with anti-inflammatory properties were selected based on the definition of the dietary inflammatory index (DII). We used Google Scholar, Pub Med, Scopus, Web of Science, Springer, Science Direct, Directory of Open Access Journals, Elsevier, Taylor and Francis, ProQuest, EBSCO, MEDLINE, and SciELO databases for extracting articles. Keywords were restricted by DII. Based on DII, food items/nutrients are involved in inflammation, some of which have anti-inflammatory and some inflammatory properties. Some foods/nutrients, in addition to their anti-inflammatory properties, have antioxidant, antiviral, and immune-enhancing properties. Considering the immune system's involvement, increased inflammation, and involvement of the pulmonary system in RVI and the remarkable role of the anti-inflammatory foods for counteracting them, it is recommended to use a predominantly anti-inflammatory diet along with prevention/control and treatment protocols. An anti-inflammatory diet (based on DII) includes turmeric, ginger, garlic, onions, saffron, dietary vitamin C, vitamin D, zinc, and omega-3 are recommended to reduce infection symptoms and duration.


Asunto(s)
Antiinflamatorios/uso terapéutico , Ácidos Grasos Omega-3/uso terapéutico , Micronutrientes/uso terapéutico , Extractos Vegetales/uso terapéutico , Infecciones del Sistema Respiratorio/dietoterapia , Virosis/dietoterapia , Virus , Adenoviridae , Antiinflamatorios/farmacología , Coronavirus , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/virología , Crocus , Dieta/clasificación , Ácidos Grasos Omega-3/farmacología , Humanos , Inflamación/dietoterapia , Inflamación/etiología , Micronutrientes/farmacología , Nutrientes/farmacología , Nutrientes/uso terapéutico , Estado Nutricional , Orthomyxoviridae , Extractos Vegetales/farmacología , Infecciones del Sistema Respiratorio/complicaciones , Infecciones del Sistema Respiratorio/prevención & control , Infecciones del Sistema Respiratorio/virología , Rhinovirus , Virosis/complicaciones , Virosis/prevención & control , Virosis/virología , Vitaminas/farmacología , Vitaminas/uso terapéutico , Zinc/farmacología , Zinc/uso terapéutico , Zingiberaceae
14.
Arch Argent Pediatr ; 119(3): e252-e255, 2021 06.
Artículo en Inglés, Español | MEDLINE | ID: mdl-34033432

RESUMEN

Coronavirus infections (CoV) are common in pediatric patients. In general, they produce a mild clinical presentation consisting of an upper respiratory tract infection that does not usually infect the lungs, with the exception of preterm infants and children with chronic diseases. These infections exceptionally affect other organs (heart, brain, gastrointestinal tract), thus increasing their severity. In relation to the temporal coincidence with the beginning of the current situation of pandemic by the new beta coronavirus SARS-CoV-2 responsible for its associated disease (COVID-19), this study presents a clinical case of a 5-year-old patient showing multiple-organ failure and neurological sequelae due to bulbar injury and vascular thrombosis caused by an alpha coronavirus (CoV-NL63) due to its severity and exceptionality.


Asunto(s)
Infecciones por Coronavirus/diagnóstico , Coronavirus Humano NL63/aislamiento & purificación , Insuficiencia Multiorgánica/virología , Infecciones del Sistema Respiratorio/diagnóstico , COVID-19/diagnóstico , Preescolar , Infecciones por Coronavirus/complicaciones , Diagnóstico Diferencial , Humanos , Insuficiencia Multiorgánica/diagnóstico , Infecciones del Sistema Respiratorio/complicaciones
16.
Multimedia | Recursos Multimedia | ID: multimedia-8770

RESUMEN

Pesquisadores e profissionais da saúde alertam para o risco que a COVID-19 pode representar em pessoas com síndrome de Down. Neste vídeo, a equipe COVID-19 DivulgAÇÃO Científica conversa com Dafne Horovitz, pesquisadora da Fundação Oswaldo Cruz, que fala sobre os impactos da COVID-19 em pessoas com síndrome de Down.


Asunto(s)
Infecciones por Coronavirus/complicaciones , Síndrome de Down/complicaciones , Investigación Científica y Desarrollo Tecnológico , e-Accesibilidad
17.
Multimedia | Recursos Multimedia | ID: multimedia-8716

RESUMEN

O Brasil é o país que mais sofre com ansiedade por causa da pandemia de COVID-19, em comparação com outros 15 países. Neste vídeo, a equipe COVID-19 DivulgAÇÃO Científica conversa com Morená Zugliani, psiquiatra do Centro Psiquiátrico do Rio de Janeiro, que fala sobre a ansiedade no contexto da COVID-19.


Asunto(s)
Investigación Científica y Desarrollo Tecnológico , Pandemias , Infecciones por Coronavirus/complicaciones , Ansiedad , Depresión , Trastornos Mentales , Promoción de la Salud , e-Accesibilidad
18.
Multimedia | Recursos Multimedia | ID: multimedia-8710

RESUMEN

Mesmo após a recuperação da COVID-19, pacientes que se infectaram com o coronavírus podem apresentar sequelas graves, como a fibrose pulmonar. Neste vídeo, a equipe COVID-19 DivulgAÇÃO Científica conversa com o imunologista Rafael Polidoro, da Escola de Medicina da Universidade de Indiana (EUA), sobre os danos causados pela COVID-19 no pulmão e como amenizá-los.


Asunto(s)
Infecciones por Coronavirus/complicaciones , Fibrosis Pulmonar , Fatiga , Depresión , Disfunción Cognitiva , Trastornos del Inicio y del Mantenimiento del Sueño , Trastornos del Olfato , e-Accesibilidad
19.
Multimedia | Recursos Multimedia | ID: multimedia-8610

RESUMEN

Even if you are young and feeling well, an infection with COVID-19 could have long-lasting consequences on your health.


Asunto(s)
Infecciones por Coronavirus/complicaciones , Neumonía Viral/complicaciones , Pandemias/prevención & control , Brote de los Síntomas , Promoción de la Salud
20.
Multimedia | Recursos Multimedia | ID: multimedia-8611

RESUMEN

Diagnosed with COVID-19 and still feeling sick for weeks or months afterwards? If you feel any COVID-19 long-term effects, ask a doctor for advice.


Asunto(s)
Infecciones por Coronavirus/complicaciones , Neumonía Viral/complicaciones , Pandemias/prevención & control , Brote de los Síntomas , Promoción de la Salud
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...